Company intelligence / Profile preview

WFMED

Ownership: Private
Employees: ~200
Development stage: Other

Overview

Wuhan Fine Medtech (WFMed) is a specialized medical device company focused on the research, development, and manufacturing of interventional cardiology and radiology products. Headquartered in Wuhan, China, the company produces a comprehensive range of vascular intervention tools, including drug-eluting stents, PTCA balloon catheters, and high-precision guidewires. WFMed is recognized for its high-quality manufacturing standards, holding ISO 13485 certification and CE marks for its primary product lines. The company serves a global market, providing both branded products and OEM/ODM manufacturing services to international partners. Its mission focuses on delivering innovative and cost-effective vascular intervention technologies to improve patient outcomes worldwide.

Therapeutic areas: Cardiovascular
Modalities: DeviceSmall molecule
Industry: Surgical Medical Devices

Beyond the preview

Go deeper on WFMED.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on WFMED.